| CAS No 188670-05-5 |
2-Ethoxy-3-hydroxypyridinenull |
Inquiry |
| CAS No 188577-69-7 |
2-Pyridinamine, 3,4-dichloro- (9CI)null |
Inquiry |
| CAS No 188577-68-6 |
2-Pyridinamine, 4,5-dichloro- (9CI)null |
Inquiry |
| CAS No 18800-53-8 |
Benzenethiol, 3,4-dimethyl- (9CI)null |
Inquiry |
| CAS No 187979-43-7 |
amino(3-methylphenyl)acetic acidnull |
Inquiry |
| CAS No 1877-72-1 |
3-Cyanobenzoic acidnull |
Inquiry |
| CAS No 18707-62-5 |
2-Furancarboxamide, N-hydroxy-N-methyl- (9CI)null |
Inquiry |
| CAS No 186593-48-6 |
3-Pyridinamine, 6-fluoro-5-methyl- (9CI)null |
Inquiry |
| CAS No 18650-39-0 |
2-Piperidinecarboxylic acid, methyl ester, (2S)- (9CI)null |
Inquiry |
| CAS No 1865-09-4 |
1H-Benzimidazole-2-carboxylic acid, ethyl ester (9CI)null |
Inquiry |
| CAS No 18645-89-1 |
1H-Benzimidazole, 4-fluoro-2-methyl- (9CI)null |
Inquiry |
| CAS No 186320-16-1 |
Benzoic acid, 2-chloro-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- (9CI)null |
Inquiry |
| CAS No 186320-13-8 |
Benzoic acid, 2-chloro-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- (9CI)null |
Inquiry |
| CAS No 185547-14-2 |
Piperazine, 1-(chloroacetyl)-4-(1-methylethyl)- (9CI)null |
Inquiry |
| CAS No 185509-76-6 |
3-Pyridinemethanamine, N-cyclobutyl- (9CI)null |
Inquiry |
| CAS No 18549-65-0 |
7-Deazapurinenull |
Inquiry |
| CAS No 1854-42-8 |
4-Amino-6,7-Dihydro-5H-Pyrrolo[3,4-d]Pyrimidinenull |
Inquiry |
| CAS No 185339-06-4 |
D-(-)-2-Hydroxyphenylglycinenull |
Inquiry |
| CAS No 185300-51-0 |
Benzene, 2-(cyclopentyloxy)-4-isocyanato-1-methoxy- (9CI)null |
Inquiry |
| CAS No 185147-06-2 |
Benzonitrile, 3-fluoro-2-methyl- (9CI)null |
Inquiry |
| CAS No 185116-43-2 |
Benzoic acid, 4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- (9CI)null |
Inquiry |
| CAS No 185116-42-1 |
Benzoic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- (9CI)null |
Inquiry |
| CAS No 1849-71-4 |
2-Benzothiazolamine, 4,5-dichloro- (9CI)null |
Inquiry |
| CAS No 1849-65-6 |
2(3H)-Benzothiazolethione, 4-chloro- (9CI)null |
Inquiry |
| CAS No 1848-84-6 |
1H-Benzimidazole, 2-ethyl- (9CI)null |
Inquiry |
